Spravato for Treatment-Resistant Depression (TRD)
Unrelenting depression getting the best of you? Have medication and therapy been ineffective? Consider Spravato.
Spravato is a twice weekly, FDA approved nasal spray designed specifically for those who are experiencing treatment resistant depression. Spravato has been proven effective for adults with Major Depressive Disorder (MDD) that have had an inadequate response to 2 or more oral anti-depressants. It is used in conjunction with a new or increased dose of a current oral anti-depressant.
Treatment
While Spravato is self-administered, patients are required to come in to Conventions Psychiatry twice weekly to administer usage under staff supervision. Patients must be also be monitored in office for two hours after each administration. This is to ensure safety and allow our certified medical professionals to assist with any side effects that may occur.
Side Effects
Most common side effects include:
- Sedation
- Dissociation
- Nausea
- Increased blood pressure
Patients must be driven home after each treatment.
Spravato is not to be used in those with a history of bleeding in the brain, aneurysm, arteriovenous malformation, substance abuse, or pregnancy.
Schedule a consultation with Michelle dela Peña to review expectations, benefits, risks, and address questions.
Schedule Your Visit
Are you ready to take the next step towards finding the attentive, compassionate, and professional help you deserve? Click below to schedule your visit today.
